BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8179993)

  • 1. Objective verification of tetanus immune status in an apparently non-immune population.
    Murphy NM; Olney DB; Brakenbury PH
    Br J Clin Pract; 1994; 48(1):8-9. PubMed ID: 8179993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunity against diphtheria and tetanus in the adult Polish population].
    Walory J; Grzesiowski P; Hryniewicz W
    Pol Merkur Lekarski; 2000 Oct; 9(52):687-92. PubMed ID: 11144058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity against diphtheria and tetanus in German blood donors.
    Aue A; Hennig H; Krüger S; Closius B; Kirchner H; Seyfarth M
    Med Microbiol Immunol; 2003 May; 192(2):93-7. PubMed ID: 12736822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated immune response to tetanus toxoid in young healthy men protected against tetanus.
    Danilova E; Shiryayev A; Kristoffersen EK; Sjursen H
    Vaccine; 2005 Oct; 23(42):4980-3. PubMed ID: 15985319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe tetanus--in spite of tetanus toxoid.
    Nivedita N
    Med J Malaysia; 1994 Mar; 49(1):105-7. PubMed ID: 8057983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiologic data for tetanus prophylaxis. Assessment of the need for vaccination].
    Brabek E; Kränke B; Stünzner D; Aberer W
    Wien Klin Wochenschr; 1999 Oct; 111(20):851-4. PubMed ID: 10586490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in anti-tetanus antibodies under sero-toxoid therapy. Study in 50 patients with tetanus].
    Goulon M; Girard O; Grosbuis S; Desormeau JP; Capponi MF
    Nouv Presse Med; 1976 Mar; 5(13):847-50. PubMed ID: 1264625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.
    Dietz V; Galazka A; van Loon F; Cochi S
    Bull World Health Organ; 1997; 75(1):81-93. PubMed ID: 9141753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sero-epidemiology of tetanus antibody among the children in eastern Turkey.
    Inandi T; Ertekin V; Ayyildiz A
    Public Health; 2002 Nov; 116(6):379-82. PubMed ID: 12407479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to a single tetanus toxoid booster in young women in rural south India.
    Aruldas K; Muliyil JP; Mathai E; Abraham S; Joseph A; Inbamalar U; Aruldas V
    Natl Med J India; 2001; 14(1):22-3. PubMed ID: 11242693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetanus booster every 5 years: an unnecessary routine?
    Chikhani CG; Kumar K
    Arch Emerg Med; 1988 Mar; 5(1):4-11. PubMed ID: 3044377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insufficient tetanus vaccination status in patients with chronic leg ulcers. Results of a prospective investigation in 100 patients.
    Korber A; Graue N; Rietkotter J; Kreuzfelder E; Grabbe S; Dissemond J
    Dermatology; 2008; 217(1):69-73. PubMed ID: 18424896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does anti-tetanus vaccination always create protective immunity?].
    Llamas Urrutia C; García Pagador E; Calderer Cardona MR; López Martínez R; Bueno García MT; De la Fuente Cadenas JA
    Rev Enferm; 2006 Jan; 29(1):7-10. PubMed ID: 16493851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of tetanus immunity in the Kocaeli Region, Turkey.
    Dundar V; Yumuk Z; Ozturk-Dundar D; Erdoğan S; Gacar G
    Jpn J Infect Dis; 2005 Oct; 58(5):279-82. PubMed ID: 16249621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of appropriate tetanus prophylaxis in an Emergency Department.
    Simşek G; Armağan E; Köksal O; Heper Y; Eraybar Pozam S; Durak VA
    Ulus Travma Acil Cerrahi Derg; 2013 Jul; 19(4):320-6. PubMed ID: 23884673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetanus immunity among pregnant women attending antenatal care in Dar es Salaam, Tanzania.
    Aboud S; Lyamuya EF; Kristoffersen EK; Matre R
    Afr J Reprod Health; 2002 Aug; 6(2):87-93. PubMed ID: 12476720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate tetanus prophylaxis practices in patients attending Emergency Departments in Italy.
    Abbate R; Di Giuseppe G; Marinelli P; Angelillo IF;
    Vaccine; 2008 Jul; 26(29-30):3634-9. PubMed ID: 18538902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated antitoxin titers in a man with generalized tetanus.
    Pryor T; Onarecker C; Coniglione T
    J Fam Pract; 1997 Mar; 44(3):299-303. PubMed ID: 9071251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunity status in confrontation with tetanigenous hazard. II. Immunity induced by a booster dose in a male population previously controlled].
    D'Arca SU; D'Arca Simonetti A; Bellante de Martiis G; Vescia N; Mastroeni I; Melino C
    Nuovi Ann Ig Microbiol; 1974; 25(2):83-119. PubMed ID: 4425172
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current trends in the use of combined serum and vaccine in tetanus prevention].
    Olivo R; Fabio U
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.